As per the report titled ‘Global Amniotic Membrane Market Size study by Type (Cryopreserved Amniotic Membrane, Lyophilized Amniotic Membrane), By Application(Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Centers and Laboratory, Others) and Regional Forecasts 2020-2026’ available with Market Study Report, global amniotic membrane market was worth USD 1 billion in the year 2019 and is projected to exhibit a robust CAGR of 12.6%, subsequently accounting for USD 2.9 billion by 2026.
 

Industry experts claim that increasing number of amniotic membrane-based transplants across the globe coupled with rising geriatric population are bolstering the growth of global amniotic membrane market size. According to NIH (National Institute of Health), global population is estimated to reach to around 1.6 billion by the end of the year 2050.
 

For those uninitiated, amniotic membrane is a mixture of cells and tissues and plays a vital role in reconstructive surgery of the eye. It possesses biological properties that helps in healing wounds by promoting re-growth of soft tissues.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2453505/
 

Furthermore, growing awareness towards the diseases associated with the membrane is positively swaying the global amniotic membrane industry dynamics. However, healthcare costs are expected to hinder the industry expansion throughout the analysis timeframe.
 

As per type, the market is segmented into lyophilized amniotic membrane and cryopreserved amniotic membrane. Moving on to application scope, global amniotic membrane market is bifurcated into prenatal diagnosis, regenerative medicine, stem cell biology, ophthalmology, surgical wounds and others.  The end user-scope of the overall market comprises of research centers & laboratory, ambulatory surgical centers, hospitals & clinics and others.
 

Regionally, Europe accounts for majority shares in global amniotic membrane market and is predicted to show similar growth through 2026. Rising prevalence of various ailments including Stevens-Johnson syndrome and cicatricial pemphigoid among European patients is propelling the expansion of the regional market.
 

Alternatively, Asia-Pacific amniotic membrane market is estimated to record the highest CAGR over 2020-2026. Rising number of surgeries as well as cosmetic and reconstruction procedures are emerging as lucrative opportunities for the industry growth.
 

The organizations that outline the global amniotic membrane industry trends are Osiris Therapeutics, Inc., Amnio Technology, LLC, Human Regenerative Technologies, LLC, Katena Products, Inc., Amniox Medical, Inc., MiMedx Group, Inc., Skye Biologics Inc., Integra Lifesciences Corporation, Alliqua BioMedical, Inc., and Applied Biologics LLC among others.